Fudan University Shanghai Cancer Hospital

Shanghai, Xuhui District 201321

0 studies enrolling now · 1 studies all time

What they study most

Platinum-resistant Ovarian Cancer

Studies at this site

• Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer — Stopped early